Hester Biosciences informs about outcome of board meeting

28 Oct 2024 Evaluate
Hester Biosciences has informed that Board of Directors, in their Meeting held today, have approved the unaudited Standalone and Consolidated Financial Results for the quarter and six months period ended 30 September 2024, as recommended by Audit Committee. It has attached the approved unaudited standalone and consolidated financial results and limited review reports; A Press Release issued in this regard the company will be publishing an extract of the results in the newspaper as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

1506.30 4.90 (0.33%)
05-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.90
Dr. Reddys Lab 1313.05
Cipla 1326.00
Zydus Lifesciences 914.45
Lupin 2332.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×